Daily Brief Podcast Podcast By Albert Takem M.D cover art

Daily Brief Podcast

Daily Brief Podcast

By: Albert Takem M.D
Listen for free

We tackle the health topics no one else wants to touch 💉🧠
—from obesity and high blood pressure
—to emotional eating and medication resistance
—to cultural myths that keep people sick 🧬❌

My mission is to deliver evidence-based truth—
real doctors. hard truths. no coddling. 🎯

🎧 Subscribe now and share with someone who’s tired of watered-down wellness.
Let’s change lives with facts—not fluff.


© 2026 Daily Brief Podcast
Hygiene & Healthy Living Physical Illness & Disease Psychology Psychology & Mental Health
Episodes
  • Ozempic Won’t “Eat Your Muscle” — Here’s the Real Fix
    Apr 20 2026

    The lecture discusses weight loss with GLP-1 medications, debunks muscle loss myths, highlights protein intake and resistance training, and advocates for informed decisions with healthcare professionals.

    In this episode, I break down the real science of weight loss with a focus on GLP-1 medications like Ozempic and Mounjaro. Using Natasha’s situation as the starting point, I address one of the biggest fears I hear in clinic: the idea that these medications “eat your muscle” and leave you weaker or looking older. I explain the truth clearly. Some lean mass loss can happen with weight loss, but that is not unique to GLP-1s. It occurs with any meaningful weight loss approach. Once you understand how the body responds to calorie restriction, the fear becomes a lot easier to manage. Then I focus on what actually protects your muscle while you lose weight. I emphasize two pillars: getting enough protein each day and doing resistance training consistently. If you want to lose fat without sacrificing strength, you need both. I close by clearing up the most common myths and reminding you that the best results come from an informed plan built with a healthcare professional, not internet advice.

    💡 Start your journey today with Maryland Primary Care & Wellness
    Book your consultation: https://www.maryland-primarycare.com/

    Show more Show less
    12 mins
  • The 3,500-Calorie Rule Works… Until It Doesn’t
    Apr 17 2026

    The episode explores the complexities of the 3,500 calorie rule in weight loss, emphasizing personalized strategies and the need for collaboration between patients and physicians to overcome plateaus and misinformation.

    In this episode, I explore the 3,500 calorie rule in relation to weight loss, prompted by concerns raised by my patient, Brittany, who experienced a plateau after losing 50 pounds. I explain the premise that a caloric deficit of 3,500 calories leads to the loss of one pound but discuss how this principle can become complicated due to metabolic adaptations over time. Sharing insights from my own weight loss journey, I address the diverse experiences of individuals, emphasizing the importance of a personalized approach to weight loss. I advocate for a collaborative relationship between physicians and patients to navigate misinformation and adapt strategies as progress slows. The episode concludes with practical advice on using the 3,500 calorie rule as a guideline while being patient with the weight loss process, reinforcing the importance of informed decision-making in healthcare.

    💡 Start your journey today with Maryland Primary Care & Wellness
    Book your consultation: https://www.maryland-primarycare.com/

    Show more Show less
    11 mins
  • Fatty Liver Can Kill You Quietly — Even If You Feel Fine
    Apr 16 2026

    Dr. Takem and Dr. Khan highlight the overlooked epidemic of fatty liver disease, stressing= the need for awareness, screenings, and lifestyle changes to combat its rising prevalence and associated health risks.

    In this episode, I’m talking about an epidemic most people have never heard of: fatty liver disease. The most alarming part is that about 95% of people who have it don’t even know it. I’m joined by my colleague Dr. Khan, who explains why fatty liver gets ignored so often. In primary care, obesity and diabetes take center stage, and fatty liver is treated like an afterthought. But it shouldn’t be, because it’s closely tied to metabolic health and it can quietly progress over time. We break down the biggest risks connected to fatty liver disease, including its strong link to cardiovascular disease and the danger of liver fibrosis. This can develop with little to no symptoms, which is exactly why so many people miss it until it’s advanced. We also talk about what to do about it. That starts with awareness and proactive screening in the right patients, and then a real treatment plan centered on lifestyle changes and long-term metabolic improvement. Fatty liver disease is rising fast, and projections suggest it will become even more common by 2050. My goal with this episode is simple: help you recognize the risk, understand what’s happening in your body, and take action early while you still have leverage.

    💡 Start your journey today with Maryland Primary Care & Wellness
    Book your consultation: https://www.maryland-primarycare.com/

    Show more Show less
    19 mins
No reviews yet